MedTrace Logo

French Cohort of Undifferentiated Spondyloarthritis

NCT01648907 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 708

Last updated 2026-03-10

No results posted yet for this study

Summary

This study is a large national multicenter, longitudinal, prospective follow-up of patients presenting with early inflammatory back pain in order to set up a database to facilitate several investigations on diagnosis, prognosis, epidemiology, pathogenesis and medico-economics in the field of early inflammatory back pain and spondyloarthritis

Conditions

  • EARLY UNDIFFERENTIATED SPONDYLARTHROPATHIES

Interventions

OTHER

Imaging exams

Radiological examinations: * Standard x-ray: they include an x-ray of the cervical, thoracic, and lumbar spine (side-on), of the lumbar spine from the front and an x-ray of the pelvis from the front * MRI scan: are taken of the cervical, thoracic and lumbar spine and sacroiliac joints. Bone densitometry: evaluation of bone densitometry of the lumbar spine and femoral neck. Enthesis ultrasound: bilateral evaluation of entheseal insertions for the Achilles tendon, patella tendons and epicondyle tendons. Biological tests : * Genetic test : DNA will be collected at the first visit from all centers. RNA will be collected at the inclusion visit in AP-HP centres only. * Serum will be collected by all centres at the initial visit, then in M6, M12 and M24 for the first two years of the study, then in M60. * Urine will be collected by all centres at the initial visit, then in M24 for the first two years of the study, then in M60.

Sponsors & Collaborators

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Maxime DOUGADOS, MD · Cochin Hospital

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-15
Primary Completion
2016-06-20
Completion
2022-02-23

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01648907 on ClinicalTrials.gov